rokitamycin

Rokitamycin is a macrolide antibiotic synthesized from strains of *Streptomyces kitasatoensis*. It is primarily active against Gram-positive bacteria and functions by inhibiting bacterial protein synthesis through specific binding to the 50S subunit of the ribosome, thereby blocking translation in susceptible organisms. This mechanism confers selectivity for prokaryotes due to the absence of 50S ribosomes in eukaryotic cells. Rokitamycin has been used mainly for respiratory tract infections and is considered well-tolerated with a low incidence of adverse reactions[3][4][5][7].

Brand names

Rokitamycin

Other names

RicamycinRokitamicinaRokitamycine